126 related articles for article (PubMed ID: 16714753)
21. Computed axial tomography tandem and ovoids (CATTO) dosimetry: three-dimensional assessment of bladder and rectal doses.
Gebara WJ; Weeks KJ; Hahn CA; Montana GS; Anscher MS
Radiat Oncol Investig; 1998; 6(6):268-75. PubMed ID: 9885943
[TBL] [Abstract][Full Text] [Related]
22. Comparison of planned and measured rectal dose in-vivo during high dose rate Cobalt-60 brachytherapy of cervical cancer.
Zaman ZK; Ung NM; Malik RA; Ho GF; Phua VC; Jamalludin Z; Baharuldin MT; Ng KH
Phys Med; 2014 Dec; 30(8):980-4. PubMed ID: 25086486
[TBL] [Abstract][Full Text] [Related]
23. Influence of brachytherapy applicators geometry on dose distribution in cervical cancer.
Senkus-Konefka E; Kobierska A; Jassem J; Serkies K; Badzio A
Strahlenther Onkol; 1997 Jun; 173(6):323-9. PubMed ID: 9209530
[TBL] [Abstract][Full Text] [Related]
24. High-dose-rate-intracavitary brachytherapy applications and the difference in the bladder and rectum doses: a study from rural centre of Maharashatra, India.
Jain VS; Sarje MB; Singh KK; Umberkar R; Shrivastava R; Jain SM
J Cancer Res Ther; 2007; 3(2):116-20. PubMed ID: 17998737
[TBL] [Abstract][Full Text] [Related]
25. Rectal wall dose-volume effect of pre- or post KUSHEN Ningjiaos relationship with 3D brachytherapy in cervical cancer patients.
Li X; Xiao C; Kong Y; Guo W; Zhan W; Li G; Wang X; Zhang B; Gao L
Radiat Oncol; 2019 Aug; 14(1):149. PubMed ID: 31429773
[TBL] [Abstract][Full Text] [Related]
26. Dose effect relationship for late side effects of the rectum and urinary bladder in magnetic resonance image-guided adaptive cervix cancer brachytherapy.
Georg P; Pötter R; Georg D; Lang S; Dimopoulos JC; Sturdza AE; Berger D; Kirisits C; Dörr W
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):653-7. PubMed ID: 21345618
[TBL] [Abstract][Full Text] [Related]
27. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915
[TBL] [Abstract][Full Text] [Related]
28. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728
[TBL] [Abstract][Full Text] [Related]
29. Screens in ovoids of a Selectron cervix applicator.
Meertens H; van der Laarse R
Radiother Oncol; 1985 Jan; 3(1):69-80. PubMed ID: 3975442
[TBL] [Abstract][Full Text] [Related]
30. Dosimetric analysis at ICRU reference points in HDR-brachytherapy of cervical carcinoma.
Eich HT; Haverkamp U; Micke O; Prott FJ; Müller RP
Rontgenpraxis; 2000; 53(2):62-6. PubMed ID: 10994367
[TBL] [Abstract][Full Text] [Related]
31. A pre-optimised dosimetry system using a rigid applicator for intracavitary treatment of cervical carcinoma.
Wong VY; Wong FC; Tung SY; Leung TW; Lui CM; Sze WK; O KS
Clin Oncol (R Coll Radiol); 2006 Oct; 18(8):612-20. PubMed ID: 17051952
[TBL] [Abstract][Full Text] [Related]
32. Influence of different Fletcher-Suit applicator geometries on sagittal dose distribution.
Palvolgyi J
Phys Med; 2010 Jan; 26(1):49-54. PubMed ID: 19386528
[TBL] [Abstract][Full Text] [Related]
33. Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations.
Lang S; Nulens A; Briot E; Kirisits C; De Brabandere M; Dumas I; Dimopoulos J; Petrow P; Georg D; Van Limbergen E; Haie-Meder C; Pötter R
Radiother Oncol; 2006 Feb; 78(2):185-93. PubMed ID: 16466820
[TBL] [Abstract][Full Text] [Related]
34. Results of a questionnaire regarding the practice of radiotherapy for carcinoma of the cervix in the UK.
Jones B; Tan LT; Blake PR; Dale RG
Br J Radiol; 1994 Dec; 67(804):1226-30. PubMed ID: 7874422
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of rectal dose during high-dose-rate intracavitary brachytherapy for cervical carcinoma.
Sha RL; Reddy PY; Rao R; Muralidhar KR; Kudchadker RJ
Med Dosim; 2011; 36(4):377-82. PubMed ID: 21144733
[TBL] [Abstract][Full Text] [Related]
36. Geometrical sparing factors for the rectum and bladder in the prediction of grade 2 and higher complications after high-dose-rate brachytherapy for cervical cancer.
Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Yang SN; Lin FJ
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1335-43. PubMed ID: 19386443
[TBL] [Abstract][Full Text] [Related]
37. Optimization in high dose rate brachytherapy for utero-vaginal applications.
Cetingöz R; Ataman OU; Tuncel N; Sen M; Kinay M
Radiother Oncol; 2001 Jan; 58(1):31-6. PubMed ID: 11165679
[TBL] [Abstract][Full Text] [Related]
38. Dosimetric comparison of vaginal vault ovoid brachytherapy versus intensity-modulated radiation therapy plans in postoperative patients of cervical carcinoma following whole pelvic radiotherapy.
Khosla D; Patel FD; Oinam AS; Tomar P; Sharma SC
J Cancer Res Ther; 2014; 10(1):153-8. PubMed ID: 24762503
[TBL] [Abstract][Full Text] [Related]
39. A dose-volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial brachytherapy for uterine cervical cancer.
Yoshida K; Yamazaki H; Takenaka T; Kotsuma T; Yoshida M; Furuya S; Tanaka E; Uegaki T; Kuriyama K; Matsumoto H; Yamada S; Ban C
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):765-72. PubMed ID: 19836165
[TBL] [Abstract][Full Text] [Related]
40. Spatial reproducibility of the ring and tandem high-dose rate cervix applicator.
Bahena JH; Martinez A; Yan D; Mele E; Edmunson G; Brown D; Hardy M; Brabbins D; Gustafson G
Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):13-9. PubMed ID: 9588912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
